glp-1 medication pregnancy safety For years, women who became pregnant while taking a were left with more questions than answers. Now, several large human studies—including a multinational study of more than 51,000 pregnancies, a Study finds no major early

Because Medicare patients often face overlapping risks such as chronic kidney disease and cardiovascular complications, multi-indication agents such as the SGLT2s remain an important complementary option alongside GLP1s

The World Health Organization is backing GLP-1 medications for the treatment of obesity, which some advocates hope will open up access to the drugs and improve affordability

This effect is often totally lost in type 2 diabetic patients

Chinese University of Hong Kong scientists call GLP-1 superstar pathway in biological, medical and pharmaceutical fields.

Originally developed and positioned as treatments for type 2 diabetes, these agents are now equally associated with weight management, reshaping how clinicians, patients, and pharmacies understand metabolic disease

Cancer represents the main cause of death worldwide